Dr. Shiver has served as Chief Strategy Officer, IGM Infectious Disease since 2021. Prior to joining IGM, he was Senior Vice President, Vaccine Research and Development at Sanofi Pasteur. Before joining Sanofi, Dr. Shiver held positions of increasing responsibility at Merck & Co., most recently as Vice President, Vaccine and Biologics Basic Research and Global Vaccine Research Franchise Head. He has also served as an Adjunct Professor at the University of Pennsylvania College of Medicine for ten years. Over the course of his career, he has contributed in a leadership capacity towards the approval of ten novel pharmaceutical products and has worked on product candidates addressing more than forty infectious and noninfectious diseases. He received a Ph.D. in Chemistry from the University of Florida and a B.S. in Chemistry and Mathematics from Wofford College.
John Shiver, Ph.D.
Chief Strategy Officer, IGM Infectious Diseases